Last updated on: 9/24/2019 | Author:

Aug. 11, 2016 – DEA Declines to Reschedule Marijuana but Opens Door to Research

“DEA [Drug Enforcement Administration] has denied two petitions to reschedule marijuana under the Controlled Substances Act (CSA)…

DEA announced a policy change designed to foster research by expanding the number of DEA-registered marijuana manufacturers. This change should provide researchers with a more varied and robust supply of marijuana… This change illustrates DEA’s commitment to working together with the FDA and NIDA to facilitate research concerning marijuana and its components.”